Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Prev Med. 2018 Dec 1;118:332–335. doi: 10.1016/j.ypmed.2018.11.020

Table 1.

Characteristics of patients by outreach group and screening status at Year 1: not screened, initiated invited screening modality, and crossed over to different screening modality (n=4,800)

FIT outreach (n==2,400) Colonoscopy outreach (n=2,400)

Not screened (n=963) Initiated FIT (n=1,359) Crossed over to colonoscopy (n=78) Not screened (n=1,335) Initiated Colonoscopy (n=613) Crossed over to FIT (n=452)
Age
 50-54 391 (40.4) 542 (56.0) 35 (3.6) 575 (55.9) 272 (26.5) 181 (17.6)
 55-59 325 (40.2) 456 (56.4) 27 (3.3) 427 (55.7) 196 (25.6) 143 (18.7)
 60-64 247 (39.6) 361 (57.9) 16 (2.6) 333 (55.0) 145 (23.9) 128 (21.1)
Sex
 Male 565 (38.3) 868 (58.9) 41 (2.8) 805 (53.9) 385 (25.8) 304 (20.4)
 Female 398 (43.0) 491 (53.0) 37 (4.0) 530 (58.5) 228 (25.2) 148 (16.3)
Race/ethnicity
 Non-Hispanic white 268 (52.1) 230 (44.8) 16 (3.1) 361 (66.9) 100 (18.5) 79 (14.6)
 Non-Hispanic black 270 (45.5) 308 (51.9) 16 (2.7) 339 (60.8) 120 (21.5) 99 (17.7)
 Hispanic 375 (32.3) 746 (64.2) 41 (3.5) 571 (48.2) 361 (30.5) 252 (21.3)
 Other 50 (38.5) 75 (57.7) 5 (3.9) 64 (54.2) 32 (27.1) 22 (18.6)
Comorbidity score
 0 429 (37.1) 681 (59.0) 45 (3.9) 628 (54.6) 318 (27.6) 205 (17.8)
 1 362 (40.8) 508 (57.3) 17 (1.9) 492 (54.6) 212 (23.5) 197 (21.9)
 2+ 172 (48.0) 170 (47.5) 16 (4.5) 215 (61.8) 83 (23.9) 50 (14.4)
Primary care visits prior to randomization
 1 392 (41.5) 533 (56.4) 20 (2.1) 586 (58.8) 234 (23.5) 176 (17.7)
 2 268 (42.0) 346 (54.2) 24 (3.8) 345 (54.7) 170 (26.9) 116 (18.4)
 3+ 303 (37.1) 480 (58.8) 34 (4.2) 404 (52.3) 209 (27.0) 160 (20.7)
Clinic type
 Neighborhood 835 (39.5) 1215 (57.5) 64 (3.0) 1161 (54.5) 541 (25.4) 428 (20.1)
 Academic 128 (44.8) 144 (50.4) 14 (4.9) 174 (64.4) 72 (26.7) 24 (8.9)